Skip to content

Will You Test Positive If You Use CBD? A Guide to the Risks

5 min read

A 2017 study found that nearly 70% of cannabidiol (CBD) products sold online were mislabeled, which can cause users to unknowingly consume THC [1.2.2, 1.5.2]. This raises a critical question for many users: will you test positive if you use CBD?

Quick Summary

Using CBD products can lead to a positive drug test. This is not because of CBD itself, but due to trace amounts of THC present in many products, especially full-spectrum CBD and those that are inaccurately labeled.

Key Points

  • THC is the Culprit: Standard drug tests screen for THC metabolites, not CBD itself. A positive test from a CBD product is caused by THC contamination [1.2.2].

  • Product Type is Key: Full-spectrum CBD contains up to 0.3% THC and poses the highest risk. CBD isolate is the purest form and the safest choice for those facing drug tests [1.3.1, 1.3.3].

  • Regulation is Lacking: The CBD market is largely unregulated by the FDA, leading to widespread product mislabeling where THC content is higher than advertised or present in "THC-free" products [1.2.2, 1.6.1].

  • Dosage Accumulates: Even small, legal amounts of THC can build up in the body with frequent, high-dose use, eventually leading to a positive test result [1.2.6, 1.5.2].

  • Verify with a COA: Always check for a recent, third-party Certificate of Analysis (COA) to confirm a product's cannabinoid profile and verify that THC levels are non-detectable ('ND') [1.7.1].

  • Topicals Are Safer: Topical applications like creams and lotions are unlikely to cause a positive test as they don't typically enter the bloodstream, unlike ingested oils or edibles [1.8.1, 1.8.3].

In This Article

The growing popularity of CBD for various wellness purposes has brought a significant concern to the forefront for employees, athletes, and anyone subject to routine drug screenings. The core of the issue is not CBD (cannabidiol) itself, but its well-known cousin, THC (tetrahydrocannabinol), the psychoactive compound that standard drug tests are designed to detect [1.2.2]. While pure CBD will not cause a positive result, the unregulated nature of the market means that THC contamination is a real and common risk [1.2.6].

How Drug Tests Detect THC

Standard drug tests, particularly urine screenings, do not look for CBD [1.2.2]. Instead, they are designed to detect THC metabolites, primarily a substance called 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) [1.4.1]. After a person consumes THC, the body metabolizes it, creating these byproducts which can be stored in body fat and are excreted over time [1.4.1, 1.2.6].

Most workplace drug testing programs follow the guidelines set by the Substance Abuse and Mental Health Services Administration (SAMHSA), which set a cutoff concentration for a positive urine test at 50 nanograms per milliliter (ng/mL) of THCCOOH [1.2.2, 1.4.4]. If the concentration in the sample exceeds this threshold, the test is considered positive [1.4.4]. Initial screenings often use an immunoassay test, and a positive result is typically confirmed with a more accurate and specific method like gas chromatography/mass spectrometry (GC-MS) to rule out false positives [1.4.3].

Types of CBD and Their Associated Risk

The single most important factor determining your risk is the type of CBD product you use. CBD extracts are generally categorized into three main types based on their cannabinoid content [1.3.1].

  • Full-Spectrum CBD: This extract contains all the cannabinoids, terpenes, and other compounds naturally found in the cannabis plant, including THC. By federal law, hemp-derived full-spectrum products must contain less than 0.3% THC by dry weight [1.2.2, 1.3.3]. While this is a small amount, regular or high-dose use can lead to THC accumulation in the body, potentially causing a positive drug test [1.2.5]. This type carries the highest risk.
  • Broad-Spectrum CBD: This type is similar to full-spectrum, containing a range of cannabinoids and terpenes, but it has undergone an additional process to remove all detectable THC [1.3.2, 1.3.4]. While this significantly lowers the risk, cross-contamination during manufacturing is still a possibility, so it's not entirely risk-free [1.2.2].
  • CBD Isolate: This is the purest form of CBD, containing 99%+ cannabidiol and no other cannabinoids or plant compounds like THC, terpenes, or flavonoids [1.3.3]. For individuals concerned about drug testing, CBD isolate is the safest option as it should not contain any THC [1.5.3].

Comparison of CBD Product Types

Feature CBD Isolate Broad-Spectrum CBD Full-Spectrum CBD
THC Content None (pure CBD) [1.3.3] No detectable THC [1.3.2] Up to 0.3% THC [1.3.1]
Drug Test Risk Lowest Low (risk of contamination) Highest
Other Cannabinoids No Yes (CBN, CBG, etc.) [1.3.2] Yes (all cannabinoids) [1.3.3]
Entourage Effect No Yes (partial) Yes (full) [1.3.4]

Factors That Can Lead to a Positive Test

Beyond product type, several other factors can influence whether using CBD results in a failed drug test:

  • Product Mislabeling and Lack of Regulation: The FDA does not regulate most CBD products in the same way as pharmaceuticals, leading to a high incidence of mislabeling [1.2.2, 1.9.5]. Studies have found that a significant portion of CBD products sold online and in stores contain different amounts of CBD than advertised, and many contain detectable levels of THC, even when labeled "THC-free" [1.6.1, 1.6.2].
  • Dosage and Frequency of Use: Consuming high doses of a CBD product, even one with less than 0.3% THC, can introduce enough THC into your system to be stored in fat cells [1.5.4]. Over time, with frequent use, these stored THC metabolites can accumulate and eventually exceed the 50 ng/mL testing threshold [1.2.6, 1.5.2].
  • Body Metabolism and Composition: Individual factors like body fat percentage, metabolism rate, and hydration levels can affect how long THC remains in your system [1.5.2, 1.5.3]. Since THC is fat-soluble, individuals with higher body fat may store THC for longer periods [1.2.6].
  • Topical vs. Ingested Products: Topical products like lotions and creams are generally considered low-risk because the cannabinoids are absorbed into the skin for localized effects and typically do not enter the bloodstream in significant amounts [1.8.1, 1.8.3]. However, transdermal patches are an exception, as they are designed to deliver cannabinoids into the bloodstream and could pose a risk if they contain THC [1.8.1]. Ingested products like oils, gummies, and capsules carry a higher risk as the compounds are processed by the body [1.8.3].

How to Minimize Your Risk

If you use CBD and are subject to drug testing, taking certain precautions can help minimize the risk of a positive result.

  1. Choose CBD Isolate or Verified Broad-Spectrum Products: To be as safe as possible, select products made with CBD isolate, which should be entirely THC-free [1.5.3]. A verified THC-free broad-spectrum product is the next best choice [1.3.2]. Avoid full-spectrum products if testing is a concern [1.5.2].
  2. Verify with a Certificate of Analysis (COA): Reputable brands provide a COA from an accredited, third-party laboratory for their products [1.5.2, 1.7.1]. This document is crucial for verifying the product's contents. When reading a COA, check the cannabinoid profile to confirm the amount of CBD and, most importantly, to ensure the THC level is listed as "ND" (Not Detected) or is below the 0.3% legal limit [1.7.1, 1.7.2]. Also, check the test date to ensure it is recent and matches the product's batch number [1.7.2].
  3. Purchase from Reputable Companies: Buy from established brands that are transparent about their manufacturing processes and readily provide COAs for every batch [1.5.1]. Avoid products that make unverified health claims, as this can be a red flag for a less-reputable company [1.6.1].

Conclusion

The answer to "Will you test positive if you use CBD?" is a definitive maybe. While CBD itself is not the problem, the widespread presence of THC in many unregulated products creates a significant risk. Product mislabeling and the accumulation of THC from full-spectrum products are the most common culprits for a failed drug test [1.2.2, 1.2.6]. By understanding the differences between CBD types, carefully vetting products with a COA, and choosing THC-free options like isolates, users can significantly reduce their risk and use CBD with greater peace of mind.

Authoritative Resource

For more information on the FDA's stance on cannabis-derived products, you can visit the FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD).

Frequently Asked Questions

Yes, it is possible. If the CBD oil is a full-spectrum product or is contaminated with THC (tetrahydrocannabinol), regular use can lead to THC accumulating in your system and causing a failed drug test [1.2.1, 1.2.2].

While 0.3% THC is a small amount, consistent or high-dose use of a product containing this concentration can lead to a buildup of THC metabolites in the body, potentially resulting in a positive drug test over time [1.2.5, 1.2.6].

CBD isolate is the safest option. It is the purest form of CBD and should contain no THC or other cannabinoids, minimizing the risk of a positive drug test [1.3.3, 1.5.3].

It is highly unlikely. Topical CBD products are absorbed by the skin for localized effects and generally do not enter the bloodstream in sufficient amounts to be detected by a drug test [1.8.1, 1.8.3]. Transdermal patches, however, are designed to enter the bloodstream and could pose a risk [1.8.1].

Look for a Certificate of Analysis (COA) from a third-party lab. Reputable brands provide this on their website. The COA's cannabinoid profile should show THC levels as 'ND' (Not Detected) or '0.0%' [1.7.1, 1.7.2].

The detection window for THC varies based on frequency of use, dosage, and individual metabolism. For a casual user, THC metabolites might be detectable in urine for a few days, while for frequent users, it can be for several weeks or even a month [1.4.4, 1.5.3].

No. The FDA has approved one CBD-based drug, Epidiolex, but it does not regulate the vast majority of over-the-counter CBD products for safety and purity. This lack of oversight is a primary reason for product mislabeling [1.2.6, 1.9.5].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.